we performed a prospective , randomized , double-blind trial in 194 unselected patients to determine the safety and efficacy of low molecular weight heparin ( fragmin ) compared with standard heparin as the initial treatment of acute venous thromboembolism .
C0019139
low molecular weight heparin
C0019134
heparin